TULSA, Okla. — A new procedure at the Oklahoma Heart Institute is changing lives for people at high risk for heart surgery.

Abbott (NYSE: ABT) has reported new data supporting its Tendyne transcatheter mitral valve replacement (TMVR) system.

Doctors at Oklahoma Heart Institute are now offering a newly FDA-approved heart valve replacement that requires no open-heart ...

Criteria for who should get heart surgery and when are based primarily on research in men, but two studies suggest this leads ...

Edwards Lifesciences (NYSE:EW) is ending its planned acquisition of JenaValve. The company is redirecting the capital that ...

To determine the best path forward, you need to work with a cardiologist. They will review the tests you had and can ...

Patients who underwent mitral valve replacement had a more than threefold higher 10-year rate of infective endocarditis than those at moderate risk for the disease, whereas undergoing mitral valve ...

With nine new procedures cleared for the da Vinci 5 robot, Intuitive’s strategy includes working with a limited number of U.S ...

For patients with failing bioprosthetic surgical mitral valves, the transcatheter mitral valve-in-valve (ViV) procedure provides early outcomes similar to those seen with repeat surgical replacement, ...

"The last few weeks have been the scariest and most eye-opening of my life," Australian content creator Leah Ramsey wrote on ...

For high-risk surgical patients with severe symptomatic mitral regurgitation (MR), insertion of the Tendyne transcatheter mitral valve replacement (TMVR; Abbott) using a cardiac transapical approach ...

Affluent Medical announced today that it rebranded to Carvolix to reflect its now-complete acquisitions of Caranx Medical and ...